Skip to content

Home
IOncology
Infectious Desease Frontier
IHepatology
Hematology Frontier
Conference topics
Experts Interviews
Informations
Live Broadcasting
Logout

Connecting Medical Expertise through Media

Search for:

Home
IOncology
Infectious Disease Frontier
International Hepatology
Hematology Frontier
Conference topics
Experts’ Interviews
Informations

Home
IOncology
Infectious Disease Frontier
International Hepatology
Hematology Frontier
Conference topics
Experts’ Interviews
Informations

Search for:

#HepatitisBResearch

Home » #HepatitisBResearch

AASLD 2024 | Dr. Hong Tang’s Team Advances HBV, MASLD, Liver Fibrosis, HCC, and ACLF Research

AASLD 2024 | Dr. Hong Tang’s Team Advances HBV, MASLD, Liver Fibrosis, HCC, and ACLF Research

Posted by

By Mourabit Halima 2024.12.24

Recently, the 75th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) was held in San Diego, USA. At the event, a team led by Dr.…

Dr. Jie Li: Exploring and Prospects of Functional Cure for Chronic Hepatitis B

Dr. Jie Li: Exploring and Prospects of Functional Cure for Chronic Hepatitis B

Posted by

By El Bachir MOURABIT 2024.09.08

Editor's Note: Achieving a functional cure for chronic hepatitis B (CHB) has become the recognized ideal treatment goal in both domestic and international guidelines, as it significantly reduces the risk…

Recent Posts

From Screening to Precision MDT: Prof. Zhang Suzhan on the “China Solution” for Colorectal Cancer
ESMO BC Voices From China | Real-World Study From Yunnan Cancer Hospital Identifies High-Risk Features Associated With Early Rapid Progression After First-Line CDK4/6 Inhibitor Therapy in HR+/HER2− Advanced Breast Cancer
Sino-French Breast Reconstruction Congress | Professor Fan Li: From “One-Size-Fits-All” Surgery to Precision Remodeling—De-escalation Strategies and the Evolving Role of Breast Surgeons in the Post-Neoadjuvant Era
ESMO BC 2026 | A Potential New First-Line “China Regimen” for Advanced TNBC: Professor Jian Zhang Reports Phase II Study of a Novel TROP2 ADC Combined With a PD-L1/VEGF-A Bispecific Antibody
ESMO BC Voices From China | Professor Nanlin Li: Neratinib-Based Combination Therapy Opens a New Path Forward for T-DXd-Resistant HR+/HER2+ Advanced Breast Cancer

Recent Comments

Archives

Categories

Artificial intelligence
Hematology Frontier
Infectious Disease Frontier
International Hepatology
IOncology
Live broadcasting
Uncategorized
UroStream

LinkedIn
Twitter
Mail

Related Media:

Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
Paris, France